
Share on:
The seven largest public orthopedic companies spent $2.3+ billion on R&D in 2019 and 2020, an expense that was about 7% of their combined sales in 2019 and 8% in 2020, according to our estimates. Click the infographic to see R&D investments by dollars and percent of sales for DePuy Synthes, Stryker, Zimmer Biomet and more.
RELATED ARTICLES
Sectra Adds Smith+Nephew 3D Templates to its Pre-op Planning Solution
Oct 16 2025 , Julie A. Vetalice
Advancing Additive Manufacturing with In-House HIP Technology
Oct 14 2025 , Paragon Medical
Amnovis Marks Milestone of 100,000 3D-Printed Implants Shipped
Oct 14 2025 , Julie A. Vetalice